DRHP

Equipped with a US FDA approved facility for 6-Chloro-Hexane-2-One, the company can develop pharma intermediates and work with…

The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…

The offer is being made through the book building process, wherein not more than 50 per cent of the offer shall be available for…

The Initial Public Offer (IPO) comprises of a fresh issue aggregating up to Rs. 12,500 million (the “Fresh Issue”) and an offer…

Offer allows Biocon to monetise its shareholding in Syngene